New Targeted Radiopharmaceutical Therapy Achieves Remission in Pancreatic Cancer Model
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
In an unprecedented leap forward for pancreatic cancer treatment, researchers have unveiled NP137, a novel therapeutic agent that appears to ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine